Ph.D., Human Genetics & Molecular Biology, Johns Hopkins School of Medicine, McKusick-Nathans Institute of Genetic Medicine, Baltimore, MD
M.S., Biotechnology: Molecular Targets & Drug Discovery, Johns Hopkins University, Baltimore, MD
B.S., Cellular & Molecular Biology, Loyola University, Baltimore, MD
Samantha leads NIST's programs supporting genome editing technologies with a primary focus on innovation in genome editing and measurements for the field of gene and cell therapies. She also works on projects supporting better measurements and assays for early detection of cancer biomarkers in collaboration with the National Cancer Institute's Early Detection Research Network. Her research is focused on measurement assurance and technology development for genome editing, bioassay and biomarker validation, with applications in engineering biology, precision/regenerative medicine, and cancer biology.
Samantha also represents the U.S. as a technical expert to the International Standards Organizations Technical Committee on Biotechnology (ISO TC 276). She is currently the U.S. liaison representing the interests and expertise of the U.S. on standards relating to nucleic acids measurements.
Postdoctoral research fellowships for U.S. citizens are available at NIST through the National Research Council http://nrc58.nas.edu/RAPLab10/Opportunity/Opportunity.aspx?LabCode=50&RO...